Some studies have indicated that high rates of Keap1 mutation and Nrf2 overexpression in papillary adenocarcinoma correlated with a poor prognosis and chemotherapy resistance [32]. The gene discussed is NFE2L2; the disease is papillary adenocarcinoma.